Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Inventory (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Inventory for 5 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory changed N/A to $6.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.7 million, a N/A change, with the full-year FY2015 number at $551008.0, up 403.96% from a year prior.
  • Inventory was $6.7 million for Q3 2025 at Soleno Therapeutics, up from $2.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $6.7 million in Q3 2025 to a low of $2.4 million in Q2 2025.